Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ehave inc investors group
Join group on Facebook
CEO Interview coming....
https://www.facebook.com/groups/177090216391858/
Back to $1.50? or has the correction in Canadian MJ's bled out?
The calm before the storm.....
Have never heard of Monster Alerts, they pack a punch?
Link to CEO on fox business
https://vimeo.com/253304954
which news letter promoted this? do you have link?
wise-man, where did you find out about $EHVVF?
Update sent out by Media One Investments this morning
List can be joined here >>
http://ehvvf.investorsmarketbuzz.com/
Happy to report from Ehave $EHVVF:
1) They expect their TSX-V listing by Summer
2) New announcements on JV w MedReleaf to come
3) They plan to pursue NASDAQ uplist
Happy to report from Ehave $EHVVF:
— Alan Weedspan (@AlanWeedspan) January 24, 2018
1) They expect their TSX-V listing by Summer
2) New announcements on JV w MedReleaf to come
3) They plan to pursue NASDAQ uplist
Confirms for me this is a long hold & more bullish. Take a look at the $RQHTF 2017 chart for what I'm expecting...
nice bids today
Let's get into the double digits first before preaching dollarama-land
Our market cap is so minuscule at these prices.
#LONG
~HS
$EHVVF Huffington post article out today
Ehave Introduces Ground-breaking Platform for Medical Marijuana Education
https://www.huffingtonpost.com/entry/ehave-introduces-ground-breaking-platform-for-medical_us_5a595f4ee4b0a233482e0b4f
Should see more volume and price reaction once listed on TSX.V
For now, great time to accumulate ;)
-HS
TSX-V listing coming
$EHVVF TSX-V listing coming shortly, be ready for fireworks✨ #medreleaf #canada #cannabis pic.twitter.com/HA1HSyGVdK
— WallStreetBets OTC (@OTCWSB) January 5, 2018
Ehave at the forefront of Canada’s medical cannabis transformation
https://usaherald.com/ehave-forefront-canadas-medical-cannabis-transformation/
$EHVVF
Ehave at the forefront of Canada’s medical cannabis transformation
https://usaherald.com/ehave-forefront-canadas-medical-cannabis-transformation/
$EHVVF
which site promoted this?
It's just small office by the sea-side, not there main head-quarters
Yes, I agree a $500M market cap is easily sustainable here in good time IMO
These fella's just opened up office next to my house in White Rock.
Great company
You do that!
The cannabis buzz is in Canada ;)
$EHVVF Positioned for growth in Canada's combusting Cannabis industry.
Having medical marijuana legalized and recreational to be instituted nationwide by July 1st 2018, Canada is the place to invest now! Canadian cannabis companies have been flying 'High' on the radar for investors around the world. Share-prices have been surging across the board, as investors pour in and companies battle to gain there market share.
The top players in the game are: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth (NASDAQOTH:TWMJF), GW Pharmaceuticals (NASDAQ:GWPH), Insys Pharmaceuticals (NASDAQ:INSY), and MedReleaf (NASDAQOTH:MEDFF)
As the big wigs battle it out, they are buying up and forming partnerships with the stronger smaller companies with promising technologies and bright futures. Just weeks ago we saw the largest hostile take-over in Canadian cannabis history, as Aurora Cannabis Announced it's Intention to Launch a Takeover Bid for CanniMed Therapeutics Inc.
These take-overs and partnerships are creating dream-like opportunities for small-cap investors abroad.
Lets look at a unique partnership between One of Canada's cannabis Giants, MedReleaf (NASDAQOTH:MEDFF) which has second-highest sales and the fourth-highest market cap among the medical cannabis stocks, and a small-cap sleeper Ehave (OTC-EHVVF).
Ehave and MedReleaf have joined forces to develop a branded MedReleaf app utilizing the Ehave Connect mental health informatics platform to advance the study and therapeutic use of medical cannabis. Ehave Connect enables developers, and ultimately prescribers, of medical cannabis to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.
Together, Ehave and MedReleaf seek to validate and optimize the use of MedReleaf's medical cannabis products as therapeutic treatments for various mental health conditions. Initially, the companies will use Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). Ultimately, it is anticipated that the MedReleaf App based on the Ehave Connect platform can be used to monitor every step of the medical cannabis treatment life cycle, from diagnosis and treatment planning to medication adherence and outcomes verification.
https://www.otcmarkets.com/stock/EHVVF/news/Ehave-and-MedReleaf-Enter-Partnership-to-Optimize-the-Therapeutic-Potential-of-Medical-Cannabis-Products?id=151088&b=y
Ehave video:
$EHVVF Positioned for growth in Canada's combusting Cannabis industry.
Having medical marijuana legalized and recreational to be instituted nationwide by July 1st 2018, Canada is the place to invest now! Canadian cannabis companies have been flying 'High' on the radar for investors around the world. Share-prices have been surging across the board, as investors pour in and companies battle to gain there market share.
The top players in the game are: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth (NASDAQOTH:TWMJF), GW Pharmaceuticals (NASDAQ:GWPH), Insys Pharmaceuticals (NASDAQ:INSY), and MedReleaf (NASDAQOTH:MEDFF)
As the big wigs battle it out, they are buying up and forming partnerships with the stronger smaller companies with promising technologies and bright futures. Just weeks ago we saw the largest hostile take-over in Canadian cannabis history, as Aurora Cannabis Announced it's Intention to Launch a Takeover Bid for CanniMed Therapeutics Inc.
These take-overs and partnerships are creating dream-like opportunities for small-cap investors abroad.
Lets look at a unique partnership between One of Canada's cannabis Giants, MedReleaf (NASDAQOTH:MEDFF) which has second-highest sales and the fourth-highest market cap among the medical cannabis stocks, and a small-cap sleeper Ehave (OTC-EHVVF).
Ehave and MedReleaf have joined forces to develop a branded MedReleaf app utilizing the Ehave Connect mental health informatics platform to advance the study and therapeutic use of medical cannabis. Ehave Connect enables developers, and ultimately prescribers, of medical cannabis to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.
Together, Ehave and MedReleaf seek to validate and optimize the use of MedReleaf's medical cannabis products as therapeutic treatments for various mental health conditions. Initially, the companies will use Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). Ultimately, it is anticipated that the MedReleaf App based on the Ehave Connect platform can be used to monitor every step of the medical cannabis treatment life cycle, from diagnosis and treatment planning to medication adherence and outcomes verification.
https://www.otcmarkets.com/stock/EHVVF/news/Ehave-and-MedReleaf-Enter-Partnership-to-Optimize-the-Therapeutic-Potential-of-Medical-Cannabis-Products?id=151088&b=y
Ehave video:
I like all of them! :)
$EHVVF Positioned for growth in Canada's combusting Cannabis industry.
Having medical marijuana legalized and recreational to be instituted nationwide by July 1st 2018, Canada is the place to invest now! Canadian cannabis companies have been flying 'High' on the radar for investors around the world. Share-prices have been surging across the board, as investors pour in and companies battle to gain there market share.
The top players in the game are: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth (NASDAQOTH:TWMJF), GW Pharmaceuticals (NASDAQ:GWPH), Insys Pharmaceuticals (NASDAQ:INSY), and MedReleaf (NASDAQOTH:MEDFF)
As the big wigs battle it out, they are buying up and forming partnerships with the stronger smaller companies with promising technologies and bright futures. Just weeks ago we saw the largest hostile take-over in Canadian cannabis history, as Aurora Cannabis Announced it's Intention to Launch a Takeover Bid for CanniMed Therapeutics Inc.
These take-overs and partnerships are creating dream-like opportunities for small-cap investors abroad.
Today we are going to look at a unique partnership between One of Canada's cannabis Giants, MedReleaf (NASDAQOTH:MEDFF) which has second-highest sales and the fourth-highest market cap among the medical cannabis stocks, and a small-cap sleeper Ehave (OTC-EHVVF).
Ehave and MedReleaf have joined forces to develop a branded MedReleaf app utilizing the Ehave Connect mental health informatics platform to advance the study and therapeutic use of medical cannabis. Ehave Connect enables developers, and ultimately prescribers, of medical cannabis to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.
Together, Ehave and MedReleaf seek to validate and optimize the use of MedReleaf's medical cannabis products as therapeutic treatments for various mental health conditions. Initially, the companies will use Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). Ultimately, it is anticipated that the MedReleaf App based on the Ehave Connect platform can be used to monitor every step of the medical cannabis treatment life cycle, from diagnosis and treatment planning to medication adherence and outcomes verification.
https://www.otcmarkets.com/stock/EHVVF/news/Ehave-and-MedReleaf-Enter-Partnership-to-Optimize-the-Therapeutic-Potential-of-Medical-Cannabis-Products?id=151088&b=y
Ehave video:
$EHVVF Positioned for growth in Canada's combusting Cannabis industry.
Having medical marijuana legalized and recreational to be instituted nationwide by July 1st 2018, Canada is the place to invest now! Canadian cannabis companies have been flying 'High' on the radar for investors around the world. Share-prices have been surging across the board, as investors pour in and companies battle to gain there market share.
The top players in the game are: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth (NASDAQOTH:TWMJF), GW Pharmaceuticals (NASDAQ:GWPH), Insys Pharmaceuticals (NASDAQ:INSY), and MedReleaf (NASDAQOTH:MEDFF)
As the big wigs battle it out, they are buying up and forming partnerships with the stronger smaller companies with promising technologies and bright futures. Just weeks ago we saw the largest hostile take-over in Canadian cannabis history, as Aurora Cannabis Announced it's Intention to Launch a Takeover Bid for CanniMed Therapeutics Inc.
These take-overs and partnerships are creating dream-like opportunities for small-cap investors abroad.
Today we are going to look at a unique partnership between One of Canada's cannabis Giants, MedReleaf (NASDAQOTH:MEDFF) which has second-highest sales and the fourth-highest market cap among the medical cannabis stocks, and a small-cap sleeper Ehave (OTC-EHVVF).
Ehave and MedReleaf have joined forces to develop a branded MedReleaf app utilizing the Ehave Connect mental health informatics platform to advance the study and therapeutic use of medical cannabis. Ehave Connect enables developers, and ultimately prescribers, of medical cannabis to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.
Together, Ehave and MedReleaf seek to validate and optimize the use of MedReleaf's medical cannabis products as therapeutic treatments for various mental health conditions. Initially, the companies will use Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). Ultimately, it is anticipated that the MedReleaf App based on the Ehave Connect platform can be used to monitor every step of the medical cannabis treatment life cycle, from diagnosis and treatment planning to medication adherence and outcomes verification.
https://www.otcmarkets.com/stock/EHVVF/news/Ehave-and-MedReleaf-Enter-Partnership-to-Optimize-the-Therapeutic-Potential-of-Medical-Cannabis-Products?id=151088&b=y
Ehave video:
Positioned for growth in Canada's combusting Cannabis industry.
Having medical marijuana legalized and recreational to be instituted nationwide by July 1st 2018, Canada is the place to invest now! Canadian cannabis companies have been flying 'High' on the radar for investors around the world. Share-prices have been surging across the board, as investors pour in and companies battle to gain there market share.
The top players in the game are: Aurora Cannabis (NASDAQOTH:ACBFF), Canopy Growth (NASDAQOTH:TWMJF), GW Pharmaceuticals (NASDAQ:GWPH), Insys Pharmaceuticals (NASDAQ:INSY), and MedReleaf (NASDAQOTH:MEDFF)
As the big wigs battle it out, they are buying up and forming partnerships with the stronger smaller companies with promising technologies and bright futures. Just weeks ago we saw the largest hostile take-over in Canadian cannabis history, as Aurora Cannabis Announced it's Intention to Launch a Takeover Bid for CanniMed Therapeutics Inc.
These take-overs and partnerships are creating dream-like opportunities for small-cap investors abroad.
Lets look at a unique partnership between One of Canada's cannabis Giants, MedReleaf (NASDAQOTH:MEDFF) which has second-highest sales and the fourth-highest market cap among the medical cannabis stocks, and a small-cap sleeper Ehave (OTC-EHVVF).
Ehave and MedReleaf have joined forces to develop a branded MedReleaf app utilizing the Ehave Connect mental health informatics platform to advance the study and therapeutic use of medical cannabis. Ehave Connect enables developers, and ultimately prescribers, of medical cannabis to design and monitor treatment plans, track patient compliance, and verify treatment outcomes in a reliable and objective manner.
Together, Ehave and MedReleaf seek to validate and optimize the use of MedReleaf's medical cannabis products as therapeutic treatments for various mental health conditions. Initially, the companies will use Ehave Connect to manage treatment plans and track patient outcomes as part of a clinical trial to evaluate medical cannabis's potential ability to provide relief to persons suffering from post-traumatic stress disorder ("PTSD"). Ultimately, it is anticipated that the MedReleaf App based on the Ehave Connect platform can be used to monitor every step of the medical cannabis treatment life cycle, from diagnosis and treatment planning to medication adherence and outcomes verification.
https://www.otcmarkets.com/stock/EHVVF/news/Ehave-and-MedReleaf-Enter-Partnership-to-Optimize-the-Therapeutic-Potential-of-Medical-Cannabis-Products?id=151088&b=y
Ehave video:
setting up here .72
$EHVVF Positioned for Growth of the Cannabis Industry
$EHVVF Positioned for Growth of the Cannabis Industry
You reckon? market cap only 40M
$63M on 1 contract, Market cap only $40M at .70
well undervalued IMO
Solid!
$SNPW news Sun Pacific Holding Corp. Projects $63 Million in Revenue from Contract
http://www.globenewswire.com/news-release/2017/12/01/1216231/0/en/Sun-Pacific-Holding-Corp-Projects-63-Million-in-Revenue-from-Contract.html
$SNPW news Sun Pacific Holding Corp. Projects $63 Million in Revenue from Contract
http://www.globenewswire.com/news-release/2017/12/01/1216231/0/en/Sun-Pacific-Holding-Corp-Projects-63-Million-in-Revenue-from-Contract.html
Loving these Canadian MJ's
Ranking the Top 4 Canadian Marijuana Stocks
MedReleaf Corp. (TSX:LEAF)
MedReleaf is another efficiency-first producer that I believe is a major underdog in the Canadian marijuana scene. Although the company went public at a tough time, shares have doubled over a few months following an inflow of many positive industry-wide developments.
MedReleaf CEO Neil Closner claims that its costs are dropping and approaching levels comparable to that of Aphria.
According to an investor presentation in August, MedReleaf holds two of 54 medical marijuana licences with a ~18% market share. That’s a huge presence, and if management can retain or even grow its market share, MedReleaf could catch Canopy off guard in a few years down the road for the title of Canada’s favourite pot stock.
https://www.fool.ca/2017/11/15/ranking-the-top-4-canadian-marijuana-stocks/
$EHVVF